Ladrx

Biotechnology Research · 2 Employees
Email Address: jcaloz@ladrxcorp.com
  • Overview
  • Employees
Access 13 Verified Employees Profiles for LadrxUnlock Free Contacts Now
About
LadRx Corporation (OTCQB: LADX) is a biopharmaceutical company with expertise in discovering and developing new therapeutics principally to treat patients with cancer. LadRx’s most recent advanced drug conjugate, aldoxorubicin, is an improved version of the widely used anti-cancer drug doxorubicin and has been out-licensed to ImmunityBio, Inc. In addition, LadRx’s drug candidate, arimoclomol, was sold to Orphazyme A/S (now Zevra Therapeutics) in exchange for milestone payments and royalties. Zevra is developing arimoclomol and is currently focused on Niemann-Pick disease Type C (NPC).
Year Founded
1985
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
--
Keywords
--
Location
map

Email Formats

Sign up for free credits and discover verified email addresses of Ladrx
FormatExamples
first + last
andywarhol@ladrxcorp.com
first_initial + last
awarhol@ladrxcorp.com
first + last_initial
andyw@ladrxcorp.com
first
andy@ladrxcorp.com
last
warhol@ladrxcorp.com
Get Verified Emails for 13 Ladrx Employees

Frequently Asked Questions

Learn More about Ladrx

Similar Companies

Biotechnology Research

Get key business info for Ladrx and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.